S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 32 of 32

Issue Date	Title / Author(s) / Citation	File
2005-01	Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa (R), ZD1839) in chemotherapy-resistant non-small cell lung cancer Han, Sae-Won; Hwang, Pil Gyu; Chung, Doo Hyun; Kim, Dong-Wan; Im, Seock-Ah; Kim, Young Tae; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong International Journal of Cancer, Vol.113 No.1, pp.109-115	DOI
2005-04	Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib Han, Sae-Won; Kim, Tae-You; Hwang, Pil Gyu; Jeong, Soohyun; Kim, Jeongmi; Choi, In Sil; Oh, Do Youn; Kim, Jee Hyun; Kim, Dong-Wan; Chung, Doo Hyun; Im, Seock-Ah; Kim, Young Tae; Lee, Jong Seok; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Journal of Clinical Oncology, Vol.23 No.11, pp.2493-2501	DOI
2006-04	Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation Han, Sae-Won; Kim, Tae-You; Jeon, Young Kyung; Hwang, Pil Gyu; Im, Seock-Ah; Lee, Kyung-Hun; Kim, Jee Hyun; Kim, Dong-Wan; Heo, Dae-Seog; Kim, Noe Kyeong; Chung, Doo Hyun; Bang, Yung-Jue Clinical Cancer Research, Vol.12 No.8, pp.2538-2544	DOI
2006-11	Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients Han, Sae-Won; Kim, Tae-You; Lee, Kyung-Hun; Hwang, Pil Gyu; Jeon, Yoon Kyung; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Heo, Dae Seog; Bang, Yung-Jue Lung Cancer, Vol.54 No.2, pp.201-207	DOI
2007-04	Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy Lee, Kyung-Hun; Im, Seock-Ah; Oh, Do-Youn; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Ha, Sung Whan; Bang, Yung-Jue BMC Cancer, Vol.7, p. 63	view file DOI
2007-05	Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer Han, Sae-Won; Jeon, Yoon Kyung; Lee, Kyung-Hun; Keam, Bhumsuk; Hwang, Pil Gyu; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Heo, Dae Seog; Bang, Yung-Jue; Kim, Tae-You Pharmacogenetics and Genomics, Vol.17 No.5, pp.313-319	DOI
2009-02	Usefulness of the whole-blood interferon-gamma release assay for diagnosis of extrapulmonary tuberculosis Song, Kyoung-Ho; Jeon, Jae Hyun; Park, Wan Beom; Kim, Sung-Han; Park, Kyoung Un; Kim, Nam Joong; Oh, Myoung-don; Kim, Hong Bin; Choe, Kang Won Diagnostic Microbiology and Infectious Disease, Vol.63 No.2, pp.182-187	DOI
2010-04	KRAS Mutant Lung Cancer Cells Are Differentially Responsive to MEK Inhibitor Due to AKT or STAT3 Activation: Implication for Combinatorial Approach Yoon, Young-Kwang; Kim, Hwang-Phill; Han, Sae-Won; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Molecular Carcinogenesis, Vol.49 No.4, pp.353-362	DOI
2010-05	Individualized Tumor Response Testing for Prediction of Response to Paclitaxel and Cisplatin Chemotherapy in Patients with Advanced Gastric Cancer Kim, Jee Hyun; Lee, Keun-Wook; Kim, Yeul Hong; Lee, Kyung Hee; Oh, Do Youn; Kim, Joonhee; Yang, Sung Hyun; Im, Seock-Ah; Choi, Sung Ho; Bang, Yung-Jue Journal of Korean Medical Science, Vol.25 No.5, pp.684-690	DOI
2013-09	How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Cancer Research and Treatment, Vol.45 No.3, pp.178-185	view file DOI
2014-02	FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study Su, X.; Zhan, P.; Gavine, P. R.; Morgan, S.; Womack, C.; Ni, X.; Shen, D.; Bang, Y-J; Im, S-A; Kim, W. Ho; Jung, E-J; Grabsch, H. I.; Kilgour, E. British Journal of Cancer, Vol.110 No.4, pp.967-975	DOI
2015-01	Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer Lee, H. J.; Seo, A. N.; Kim, E. J.; Jang, M. H.; Kim, Y. J.; Kim, J. H.; Kim, S. -W.; Ryu, H. S.; Park, I. A.; Im, S. -A.; Gong, G.; Jung, K. H.; Kim, H. J.; Park, S. Y. British Journal of Cancer, Vol.112 No.1, pp.103-111	DOI
2016-04	Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications Ock, Chan-Young; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Gastric Cancer, Vol.19 No.2, pp.421-430	DOI
2016-07	Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer Suh, Koung Jin; Ryu, Han Suk; Lee, Kyung-Hun; Kim, Hyojin; Min, Ahrum; Kim, Tae-Yong; Yang, Yaewon; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Im, Seock-Ah Breast Cancer Research and Treatment, Vol.158 No.2, pp.233-241	DOI
2017-01	Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells Kim, Hee-Jun; Min, Ahrum; Im, Seock-Ah; Jang, Hyemin; Lee, Kyung Hun; Lau, Alan; Lee, Miso; Kim, Seongyeong; Yang, Yaewon; Kim, Jungeun; Kim, Tae Yong; Oh, Do-Youn; Brown, Jeffrey; O'Connor, Mark J.; Bang, Yung-Jue International Journal of Cancer, Vol.140 No.1, pp.109-119	DOI
2017-04	AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells Min, Ahrum; Im, Seock-Ah; Jang, Hyemin; Kim, Seongyeong; Lee, Miso; Kim, Debora Keunyoung; Yang, Yaewon; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Jin Won; Kim, Tae-Yong; Oh, Do-Youn; Brown, Jeff; Lau, Alan; O'Connor, Mark J.; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.16 No.4, pp.566-577	DOI
2017-06	Digital micromirror based near-infrared illumination system for plasmonic photothermal neuromodulation Jung, Hyunjun; Kang, Hongki; Nam, Yoonkey Biomedical Optics Express, Vol.8 No.6, pp.2866-2878	DOI
2017-12	Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study Ott, Patrick A.; Elez, Elena; Hiret, Sandrine; Kim, Dong-Wan; Morosky, Anne; Saraf, Sanatan; Piperdi, Bilal; Mehnert, Janice M. Journal of Clinical Oncology, Vol.35 No.34, pp.3823-3829	DOI
2018-05	Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells Min, Ahrum; Kim, Jung Eun; Kim, Yu-Jin; Lim, Jee Min; Kim, Seongyeong; Kim, Jin Won; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Bang, Yung-Jue; Im, Seock-Ah Cancer Letters, Vol.430, pp.123-132	DOI
2018-05	Thermo-plasmonic gold nanofilms for simple and mass-producible photothermal neural interfaces Lee, Jee Woong; Kang, Hongki; Nam, Yoonkey Nanoscale, Vol.10 No.19, pp.9226-9235	DOI
2018-06	Clinicopathologic implication of microRNA-197 in diffuse large B cell lymphoma Yang, Jeong Mi; Jang, Ji-Young; Jeon, Yoon Kyung; Paik, Jin Ho Journal of Translational Medicine, Vol.16 No.1, p. 162	DOI
2018-12	Activation of LXR?/ by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer Kim, Soochi; Lee, Maria; Dhanasekaran, Danny N.; Song, Yong Sang BMC Cancer, Vol.18, p. 1232	DOI
2019-09	GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer Park, Ji Eun; Jin, Mei Hua; Hur, Minkyu; Nam, Ah-Rong; Bang, Ju-Hee; Won, Jonghwa; Oh, Do-Youn; Bang, Yung-Jue Gastric Cancer, Vol.22 No.5, pp.932-940	DOI
2019-12	Targeted next-generation DNA sequencing identifies Notch signaling pathway mutation as a predictor of radiation response Jeon, Seung Hyuck; Chie, Eui Kyu; Kim, Yi-Jun; Lee, Kyung-Hun; Lee, Hyun-Seob; Kim, Min Jung; Im, Seock-Ah; Kim, Jong-Il; Kim, Tae-You International Journal of Radiation Biology, Vol.95 No.12, pp.1640-1647	DOI
2020-02	Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts Bang, Yung-Jue; Su, Wu-Chou; Schuler, Martin; Nam, Do-Hyun; Lim, Wan Teck; Bauer, Todd M.; Azaro, Analia; Poon, Ronnie Tung Ping; Hong, David; Lin, Chia-Chi; Akimov, Mikhail; Ghebremariam, Samson; Zhao, Sylvia; Giovannini, Monica; Ma, Brigette Cancer Science, Vol.111 No.2, pp.536-547	DOI
2020-02	TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy Kim, Jin Won; Min, Ahrum; Im, Seock-Ah; Jang, Hyemin; Kim, Yu Jin; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Lee, Keun Wook; Oh, Do-Youn; Kim, Jee-Hyun; Bang, Yung-Jue Cancers, Vol.12 No.2, p. 334	view file DOI
2021-10	Potential role of CMPK1, SLC29A1, and TLE4 polymorphisms in gemcitabine-based chemotherapy in HER2-negative metastatic breast cancer patients: pharmacogenetic study results from the prospective randomized phase II study of eribulin plus gemcitabine versus paclitaxel plus gemcitabine (KCSG-BR-13-11) Cho, E. H.; Kim, J. -Y.; Im, S. -A.; Jung, K. H.; Sohn, J.; Lee, K. S.; Chae, Y. S.; Lee, K. H.; Kim, J. H.; Jang, J. -H.; Ahn, J. H.; Park, M. S.; Lee, S. -Y.; Park, Y. H. Esmo Open, Vol.6 No.5, p. 100236	DOI
2021-11	Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors in Patients With De Novo EGFR(T790M)-Mutant NSCLC Park, Ha-Ram; Kim, Tae Min; Lee, Yusoo; Kim, Soyeon; Park, Seongyeol; Ju, Young Seok; Kim, Miso; Keam, Bhumsuk; Jeon, Yoon Kyung; Kim, Dong-Wan; Heo, Dae Seog Journal of Thoracic Oncology, Vol.16 No.11, pp.1859-1871	DOI
2022-06	Semi-Transparent, Micrometer Resolution p-NiO/n-ZnO Heterojunction Diode Temperature Sensors with Ultrathin Metal Anode Lee, Junhee; Hong, Nari; Hong, Woongki; Kim, Duhee; Hwang, Yujin; Jang, Jaewon; Kang, Hongki Advanced Materials Technologies, Vol.7 No.6, p. 2100923	DOI
2022-10	Establishment and Characterization of Carboplatin-Resistant Retinoblastoma Cell Lines Cho, Chang Sik; Jo, Dong Hyun; Kim, Jin Hyoung; Kim, Jeong Hun Molecules and Cells, Vol.45 No.10, pp.729-737	DOI
2022-11	Accurate Diagnosis of COVID-19 from Self-Collectable Biospecimens Using Synthetic Apolipoprotein H Peptide-Coated Nanoparticle Assay Kang, Junwon; Jang, Haewook; Kim, Tae Hyun; Cho, Untack; Bang, Hyeeun; Jang, Jisung; Lee, Wooseok; Joo, Hyelyn; Noh, Jinsung; Lee, Gi Yoon; Shin, Dong Hoon; Kang, Chang Kyung; Choe, Pyoeng Gyun; Kim, Nam Joong; Oh, Myoung-don; Song, Manki; Kwon, Sunghoon; Veas, Francisco; Park, Wan Beom Analytical Chemistry, Vol.94 No.49, pp.17186-17194	DOI
2023-05	Genetic and immune microenvironment characterization of HER2-positive gastric cancer: Their association with response to trastuzumab-based treatment Kwon, Hyun Jung; Park, Yujun; Nam, Soo Kyung; Kang, Enoch; Kim, Ka-Kyung; Jeong, Inhae; Kwak, Yoonjin; Yoon, Jeesun; Kim, Tae-Yong; Lee, Keun-Wook; Oh, Do-Youn; Im, Seock-Ah; Kong, Seong-Ho; Park, Do Joong; Lee, Hyuk-Joon; Kim, Hyung-Ho; Yang, Han-Kwang; Lee, Hye Seung Cancer Medicine, Vol.12 No.9, pp.1-14	DOI